WuXi Biologics ISIN: KYG970081173 Forum: Aktien User: Summer.76

WuXi Biologics Released a New cGMP Drug Product Manufacturing Facility to Support End-to-End Services for Diversified Modalities https://www.prnewswire.com/news-releases/wuxi-biologics-released-a-new-cgmp-drug-product-manufacturing-facility-to-support-end-to-end-services-for-diversified-modalities-301656720.html • WuXi Biologics adds further capacity and capability for drug product fill & finish, providing global customers with end-to-end integrated solutions for diversified modalities, including mRNA-LNP

Sie kaufen ja immer günstiger zurück 😉 ich hoffe, dass hier bald Mal etwas Stabilität zurückkehrt.

WuXi Biologics (02269 HK) repurchased 5 million shares with a capital of 236 million yuan https://hk.news.yahoo.com/%E8%97%A5%E6%98%8E%E7%94%9F%E7%89%A9-02269-hk-%E5%9B%9E%E8%B3%BC500%E8%90%AC%E8%82%A1-%E6%B6%89%E8%B3%872-201843656.html

WuXi Biologics (02269 HK) repurchased 3.2 million shares yesterday, involving nearly 160 million yuan http://www.aastocks.com/tc/stocks/news/aafn-news/NOW.1220037/2

WuXi Biologics (02269 HK) repurchased 5 million shares yesterday, involving 236 million http://www.aastocks.com/tc/stocks/news/aafn-news/NOW.1219105/3

WuXi Biologics Receives "Best CDMO Award of the Year" https://www.prnewswire.com/news-releases/wuxi-biologics-receives-best-cdmo-award-of-the-year-301648370.html ...The winners were determined through voting by more than 200 biopharma companies and service providers involved in biologics manufacturing in the APAC regions. ...

WUXI BIO Buys back 2.589M Shrs Ytd for Almost $120M http://www.aastocks.com/en/stocks/news/aafn-con/NOW.1218562/company-news/HK6

WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody https://www.prnewswire.com/news-releases/wuxi-biologics-and-toregem-biopharma-sign-mou-for-development-of-anti-usag-1-antibody-301645454.html

Minsheng Securities: Maintain WuXi Biologics (02269) "Recommended" rating, remove UVL list, release bottom reversal signal https://hk.investing.com/news/stock-market-news/article-259245

Dahang Report" Morgan Stanley: WuXi Biologics (02269 HK) Subsidiary Removal From Unverified List Expects Positive Share Price Reaction http://www.aastocks.com/tc/stocks/news/aafn-news/NOW.1218122/2

http://www.aastocks.com/en/stocks/news/aafn-con/NOW.1218064/company-news/HK6 Nomura Keeps WUXI BIO as Top Pick with Buy Rating on Subsidiary's Removal from UVL

Zhongtai Securities: Maintain "Buy" rating on WuXi Biologics (02269), optimistic about the continuous realization of the CRDMO business model https://hk.investing.com/news/stock-market-news/article-259060

https://www.prnewswire.com/news-releases/wuxi-biologics-co-ltd-removed-from-unverified-list-301644353.html

https://equalocean.com/news/2022100919004

WuXi Biologics: Geopolitical Risks Draw Investors' Attention https://seekingalpha.com/article/4545243-wuxi-biologics-geopolitical-risks-draw-investors-attention

U.S. adds China's YMTC and 30 other firms to 'unverified' trade list https://www.reuters.com/business/us-adds-dozens-chinese-firms-export-control-list-2022-10-07/ ... The United States removed a unit of Wuxi Biologics from the list on Friday, good news for the maker of ingredients for AstraZeneca's COVID-19 vaccine. Reuters reported last summer that U.S. officials had been able to conduct an inspection at the Wuxi city site, a stepping stone to removal from the list. A Wuxi Biologics spokeswoman said on Friday the company was pleased the Wuxi site was removed from the list, given the inspection in June. The company looks forward to scheduling an inspection of its Shanghai subsidiary, which also was placed on the unverified list in February, she added.